News About: Pharm. Industry
Multinational drug manufacturers’ revenues up, profit down
28 foreign-invested firms, except for Pfizer Korea, Janssen Korea and Boehringer Ingelheim Korea, saw their revenues jump last year, but their ability to generate cash from a variety of operating activities fell on wo...
Bausch & Lomb Korea spends 19.9% of revenue on promotion
Details of multinational drug manufacturers’ spending revealed on April 13 show that Bausch & Lomb Korea spent 19.9 percent of its annual sales on advertisements and entertainment, or 4.1 billion won last year.
In ...
Gov’t seeks to revise laws to punish rebate takers, givers
The government has unveiled its fight against chronic illegal rebate practices whereby doctors and pharmacists receive money from drug makers in return for prescribing or recommending their products.
The wholesale...
Doctors acts to cut pill prescriptions
Doctors are launching a campaign to reduce unnecessary pill prescriptions at medical clinics and hospitals, according to the Korean Medical Association (KMA).
KMA officials said the lobby group has encouraged hospi...
Ildong wins local patent for donepezil HCl
Ildong Pharm said in a regulatory filing on April 8 that it has acquired a Korean process patent for donepezil HCl, an agent for the treatment of Alzheimer's disease.
The innovated drug manufacturing technology con...
Government awards Green Cross
The government awarded on April 7 a Presidential Award to Green Cross Corporation, honoring its business achievements and contributions to the development of a vaccine against the influenza at a ceremony to mark the 3...
KPA to return herbal drinks containing excessive contents of preservative
The Korea Pharmaceutical Association plans to return all herbal drinks exceeding the acceptable limit (0.06%) of a preservative.
The move came after some media reported that some herbal drinks exceeding the accepta...
Drug makers to face uphill battle over drug pricing
A report, released by the Health Insurance Review Assessment and Service on April 6, will mostly affect the revenue of pharmaceutical firms that sell antihypertensive drugs.
Based on the previous report of Professo...
Dong-A picked for Samchully Pharm takeover
Dong-A Pharmaceutical Co., the nation’s leading drug maker, has been picked as a preferred bidder for Samchully Pharm, according to market sources.
The sources also said Green Cross Corp. and Handok Pharm showed a ...
Green Cross to develop cell-based pandemic vaccines
Green Cross Corp., said on April 6 that it intends to enhance the nation’s preparedness for an influenza pandemic by improving on existing vaccine production techniques using egg-based vaccine, through the development...
